BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4425 related articles for article (PubMed ID: 6555061)

  • 1. Detection of phenotypic differences on human malignant melanoma lines and their variant sublines with monoclonal antibodies.
    Brüggen J; Sorg C
    Cancer Immunol Immunother; 1983; 15(3):200-5. PubMed ID: 6555061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common human melanoma-associated antigen(s) detected by monoclonal antibodies.
    Carrel S; Accolla RS; Carmagnola AL; Mach JP
    Cancer Res; 1980 Jul; 40(7):2523-8. PubMed ID: 6155995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimelanoma hybridoma antibodies against partially purified melanoma antigen.
    Medrano L; Cesarini JP; Daveau M; Phillips J; Salazar G; Fontaine M; Phillips T; Viza D; Prunieras M
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):153-61. PubMed ID: 6337853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.
    Houghton AN; Brooks H; Cote RJ; Taormina MC; Oettgen HF; Old LJ
    J Exp Med; 1983 Jul; 158(1):53-65. PubMed ID: 6864164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition of human melanoma-associated cell surface antigens by hybridoma monoclonal antibodies.
    Burk MW; Saxton RE; Mann BD; Morton DL
    Surgery; 1983 Jul; 94(1):84-90. PubMed ID: 6857516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
    Saxton RE; Mann BD; Morton DL; Burk MW
    Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies against human malignant melanoma.
    Sorg C; Brüggen J; Suter L; Bröcker EB
    Bull Cancer; 1983; 70(2):113-7. PubMed ID: 6871486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms.
    Woodbury RG; Brown JP; Yeh MY; Hellström I; Hellström KE
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2183-7. PubMed ID: 6929544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanoma.
    Martin RF; Kisor R; Schroer D; Eichler G; Filaccio ML
    Hum Antibodies Hybridomas; 1990; 1(3):154-9. PubMed ID: 2103359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine hybridoma antibodies against human transitional carcinoma-associated antigens.
    Messing EM; Bubbers JE; Whitmore KE; deKernion JB; Nestor MS; Fahey JL
    J Urol; 1984 Jul; 132(1):167-72. PubMed ID: 6202893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue specificity of anti melanoma monoclonal antibodies analyzed on cell lines.
    Johnson JP; Riethmüller G
    Hybridoma; 1982; 1(4):381-5. PubMed ID: 6208134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to tumor antigens.
    Hellström KE; Brown JP; Hellström I
    Contemp Top Immunobiol; 1980; 11():117-37. PubMed ID: 6160947
    [No Abstract]   [Full Text] [Related]  

  • 14. Reactivity spectrum of 30 monoclonal antimelanoma antibodies to a panel of 28 melanoma and control cell lines.
    Carrel S; Schreyer M; Schmidt-Kessen A; Mach JP
    Hybridoma; 1982; 1(4):387-97. PubMed ID: 6208135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class 1 (unique) tumor antigens of human melanoma: identification of unique and common epitopes on a 90-kDa glycoprotein.
    Real FX; Furukawa KS; Mattes MJ; Gusik SA; Cordon-Cardo C; Oettgen HF; Old LJ; Lloyd KO
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3965-9. PubMed ID: 2453881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue origin.
    Johnson JP; Demmer-Dieckmann M; Meo T; Hadam MR; Riethmüller G
    Eur J Immunol; 1981 Oct; 11(10):825-31. PubMed ID: 6895502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of monoclonal antibodies to human melanoma-associated antigens.
    Imai K; Ng AK; Ferrone S
    J Natl Cancer Inst; 1981 Mar; 66(3):489-96. PubMed ID: 6162991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Workshop on monoclonal antibodies to human melanoma-associated antigens: findings of the Seattle group.
    Hellström I; Brown JP; Hellström KE
    Hybridoma; 1982; 1(4):399-402. PubMed ID: 6208136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common neuroectodermal antigens on human melanoma, neuroblastoma, retinoblastoma, glioblastoma and fetal brain revealed by hybridoma antibodies raised against melanoma cells.
    Liao SK; Clarke BJ; Kwong PC; Brickenden A; Gallic BL; Dent PB
    Eur J Immunol; 1981 Jun; 11(6):450-4. PubMed ID: 7262181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro immunization of human B lymphocytes with cultured melanoma cells (SK-MEL 28).
    Zhang XM; Borrebaeck CA
    Hum Antibodies Hybridomas; 1990; 1(1):42-6. PubMed ID: 1966473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 222.